ACADIA Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.About ACAD
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
CEOCatherine Owen Adams
CEOCatherine Owen Adams
Employees654
Employees654
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1993
Founded1993
Employees654
Employees654
ACAD Key Statistics
Market cap3.57B
Market cap3.57B
Price-Earnings ratio15.85
Price-Earnings ratio15.85
Dividend yield—
Dividend yield—
Average volume1.58M
Average volume1.58M
High today$22.21
High today$22.21
Low today$21.04
Low today$21.04
Open price$21.67
Open price$21.67
Volume1.50M
Volume1.50M
52 Week high$25.23
52 Week high$25.23
52 Week low$13.40
52 Week low$13.40
ACAD News
Simply Wall St 7d
ACADIA Pharmaceuticals Inc. Surges 54% Yet Its Low P/S Is No Reason For ExcitementACADIA Pharmaceuticals Inc. ( ) shares have had a really impressive month, gaining 54% after a shaky period beforehand. The last 30 days bring the annual gain t...
Analyst ratings
63%
of 19 ratingsBuy
63.2%
Hold
31.6%
Sell
5.3%
People also own
Based on the portfolios of people who own ACAD. This list is generated using Robinhood data, and it’s not a recommendation.